Managers / Q4 2022 · view latest →
Tyrus Capital S.A.M.
CIK 0001543065 · 9 AVENUE J.F. KENNEDY, MONACO, O9, MC 98000 · 377 9999 5030
Summary
Tyrus Capital S.a.m. reported $46M in U.S.-listed holdings across 45 positions for Q4 2022.
Its largest position, Golden Falcon Acquisition, represents 14.9% of the portfolio.
Compared with Q3 2019, the fund opened 45 new positions and exited 1.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Other · 77.7% · $36M
- Common Stock · 22.2% · $10M
- Equity WRT · 0.1% · $45,130
Quarter-over-Quarter Changes full breakdown →
vs Q3 2019 (amended baseline) · note: prior filed quarter, not the immediately preceding one
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| GOLDEN FALCON ACQUISITION CO | NEW | +676.7K | 676.7K | +$7M | $7M |
| AVIRATEA PHARMACEUTICALS INC | NEW | +1.26M | 1.26M | +$6M | $6M |
| LAZARD GROWTH ACQUISITION CO | NEW | +500.0K | 500.0K | +$5M | $5M |
| GSMFERROGLOBE PLC | NEW | +1.08M | 1.08M | +$4M | $4M |
| EUROPEAN BIOTECH ACQUTN CORP | NEW | +400.0K | 400.0K | +$4M | $4M |
| GLOBAL PARTNER ACQISTN CORP | NEW | +200.0K | 200.0K | +$2M | $2M |
| TECH AND ENERGY TRANSITION | NEW | +200.0K | 200.0K | +$2M | $2M |
| MARLIN TECHNOLOGY CORP | NEW | +150.0K | 150.0K | +$2M | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2022
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | GOLDEN FALCON ACQUISITION CO | CL A · *W EXP 11/04/202 | 14.87% | $7M | 1.10M |
| 2 | AVIRATEA PHARMACEUTICALS INChistory → | COM | 13.20% | $6M | 1.26M |
| 3 | LAZARD GROWTH ACQUISITION CO | CL A ORD SHS · *W EXP 02/10/202 | 11.00% | $5M | 600.0K |
| 4 | GSMFERROGLOBE PLChistory → | SHS | 9.03% | $4M | 1.08M |
| 5 | EUROPEAN BIOTECH ACQUTN CORP | CLASS A ORD SHS · *W EXP 03/06/202 | 8.89% | $4M | 533.3K |
| 6 | GLOBAL PARTNER ACQISTN CORP | CL A SHS · *W EXP 01/14/202 | 4.41% | $2M | 233.3K |
| 7 | TECH AND ENERGY TRANSITION | CLASS A COM · *W EXP 03/31/202 | 4.38% | $2M | 266.7K |
| 8 | MARLIN TECHNOLOGY CORP | CL A SHS | 3.31% | $2M | 150.0K |
| 9 | DHC ACQUISITION CORP | CLASS A ORD SHS · *W EXP 02/25/202 | 3.29% | $2M | 200.0K |
| 10 | ALTIMAR ACQUISITION CORP III | SHS CL A | 3.02% | $1M | 137.8K |
| 11 | TARGET GLOBAL ACQUISI I CORP | UNIT 99/99/9999 | 2.80% | $1M | 125.0K |
| 12 | L CATTERTON ASIA ACQUISITION | CLASS A ORD SHS · *W EXP 03/08/202 | 2.20% | $1M | 133.3K |
| 13 | FINTECH EVOLUTION ACQUIS GRO | SHS CL A | 2.20% | $1M | 100.0K |
| 14 | LEVERE HOLDINGS CORP | CLASS A ORD SHS · *W EXP 03/09/202 | 2.20% | $1M | 133.3K |
| 15 | DEEP LAKE CAPITAL ACQUSTN CO | CL A SHS | 2.20% | $1M | 100.0K |
| 16 | MOTIVE CAPITAL CORP II | UNIT 99/99/9999 | 2.11% | $967,240 | 92.4K |
| 17 | KERNEL GROUP HOLDINGS INC | CL A SHS · *W EXP 02/02/202 | 1.98% | $909,257 | 135.0K |
| 18 | JUPITER ACQUISITION CORP | UNIT 09/11/2027 | 1.62% | $745,500 | 75.0K |
| 19 | FORBION EUROPEAN ACQUSTN COR | UNIT 12/10/2026 | 1.13% | $516,500 | 50.0K |
| 20 | CRESCERA CAP ACQUISITION COR | UNIT 11/18/2026 | 1.11% | $511,000 | 50.0K |
| 21 | ARES ACQUISITION CORPORATION | COM CL A · *W EXP 02/02/202 | 1.11% | $508,163 | 60.0K |
| 22 | FTAC ATHENA ACQUISITION CORP | CL A SHS · *W EXP 03/01/202 | 1.10% | $505,275 | 62.5K |
| 23 | TWIN RIDGE CAPITAL ACQUIS CO | SHS CL A · *W EXP 03/07/202 | 1.10% | $505,002 | 66.7K |
| 24 | DISRUPTIVE ACQUISITION CORP | CLASS A ORD SHS · *W EXP 03/06/202 | 1.10% | $504,442 | 66.7K |
| 25 | SVF INVESTMENT CORP | CL A SHS | 0.28% | $126,375 | 12.5K |
| 26 | SCION TECH GROWTH II | CL A SHS | 0.22% | $101,200 | 10.0K |
| 27 | RUMBWRUMBLE INC | *W EXP 09/16/202 | 0.07% | $34,375 | 27.5K |
| 28 | WALDENCAST PLC | *W EXP 07/27/202 | 0.05% | $20,666 | 33.3K |
| 29 | BZFDWBUZZFEED INC | *W EXP 12/03/202 | 0.01% | $6,667 | 166.7K |
| 30 | PIIIWP3 HEALTH PARTNERS INC | *W EXP 11/19/202 | 0.01% | $3,576 | 25.5K |
| 31 | THUNDER BRIDGE CAP PRTNRS II | *W EXP 02/01/202 | 0.00% | $767 | 10.0K |
| 32 | BBAI/WSBIGBEAR AI HLDGS INC | *W EXP 12/08/202 | 0.00% | $512 | 16.7K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2023 | $11M | 27 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $14M | 28 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $17M | 32 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $46M | 45 | Feb 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $1M | 1 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $0 | 1 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $2M | 2 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.